Acurx Pharmaceuticals Statistics
Total Valuation
ACXP has a market cap or net worth of $22.58 million. The enterprise value is $16.82 million.
| Market Cap | 22.58M |
| Enterprise Value | 16.82M |
Important Dates
The last earnings date was Tuesday, November 12, 2024, after market close.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ACXP has 16.25 million shares outstanding. The number of shares has increased by 27.05% in one year.
| Current Share Class | 16.25M |
| Shares Outstanding | 16.25M |
| Shares Change (YoY) | +27.05% |
| Shares Change (QoQ) | +3.40% |
| Owned by Insiders (%) | 14.80% |
| Owned by Institutions (%) | 12.42% |
| Float | 13.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 8.75 |
| P/TBV Ratio | 8.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.80
| Current Ratio | 1.80 |
| Quick Ratio | 1.77 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -498.16% and return on invested capital (ROIC) is -311.35%.
| Return on Equity (ROE) | -498.16% |
| Return on Assets (ROA) | -156.34% |
| Return on Capital (ROIC) | -311.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.11M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.43% in the last 52 weeks. The beta is -1.72, so ACXP's price volatility has been lower than the market average.
| Beta (5Y) | -1.72 |
| 52-Week Price Change | -62.43% |
| 50-Day Moving Average | 1.93 |
| 200-Day Moving Average | 2.22 |
| Relative Strength Index (RSI) | 14.25 |
| Average Volume (20 Days) | 88,617 |
Short Selling Information
The latest short interest is 474,480, so 2.92% of the outstanding shares have been sold short.
| Short Interest | 474,480 |
| Short Previous Month | 501,924 |
| Short % of Shares Out | 2.92% |
| Short % of Float | 3.43% |
| Short Ratio (days to cover) | 12.59 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.44M |
| Pretax Income | -16.73M |
| Net Income | -16.44M |
| EBITDA | n/a |
| EBIT | -16.44M |
| Earnings Per Share (EPS) | -$1.07 |
Balance Sheet
| Cash & Cash Equivalents | 5.76M |
| Total Debt | n/a |
| Net Cash | 5.76M |
| Net Cash Per Share | $0.35 |
| Equity (Book Value) | 2.66M |
| Book Value Per Share | 0.16 |
| Working Capital | 2.66M |
Cash Flow
| Operating Cash Flow | -12.33M |
| Capital Expenditures | n/a |
| Free Cash Flow | -12.33M |
| FCF Per Share | -$0.76 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACXP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.05% |
| Shareholder Yield | -27.05% |
| Earnings Yield | -72.79% |
| FCF Yield | -54.61% |
Analyst Forecast
The average price target for ACXP is $12.00, which is 763.31% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 763.31% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 29.51% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |